{
    "title": "Maker of coronavirus trial drug aims for wide distribution -Gilead CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8277803/Coronavirus-trial-drug-remdesivirs-maker-aims-wide-distribution-Gilead-CEO.html",
    "date": "2020-05-01",
    "keywords": [
        "covid19",
        "treatment",
        "drug",
        "remdesivir",
        "trial",
        "coronavirus",
        "gilead",
        "company",
        "fda",
        "drugmaker",
        "production",
        "officer",
        "daniel",
        "oday",
        "interest",
        "government",
        "wednesday",
        "illness",
        "placebo",
        "today",
        "responsibility",
        "difference",
        "globe",
        "collaboration",
        "food",
        "administration",
        "action",
        "thursday",
        "conference",
        "call",
        "medicine",
        "trading",
        "stock",
        "year",
        "date",
        "response",
        "wall",
        "street",
        "friday",
        "report",
        "capital",
        "analyst",
        "brain",
        "management",
        "distribution",
        "balance",
        "access",
        "sustainability",
        "unpredictability",
        "impact",
        "reporting",
        "doina",
        "chiacu",
        "washington",
        "manojna",
        "maddipatla",
        "ankur",
        "banerjee",
        "bengaluru",
        "editing",
        "john",
        "stonestreet",
        "alexander",
        "smithjane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}